Weekly Research Analysts’ Ratings Updates for Tenet Healthcare (THC)

Several analysts have recently updated their ratings and price targets for Tenet Healthcare (NYSE: THC):

• 2/13/2026 – Tenet Healthcare had its price target raised by analysts at Guggenheim from $257.00 to $271.00. They now have a “buy” rating on the stock.
• 2/13/2026 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a $257.00 price target on the stock.
• 2/12/2026 – Tenet Healthcare had its price target raised by analysts at UBS Group AG from $260.00 to $288.00. They now have a “buy” rating on the stock.
• 2/12/2026 – Tenet Healthcare had its “buy” rating reaffirmed by analysts at TD Cowen.
• 2/12/2026 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $260.00 price target on the stock.
• 2/12/2026 – Tenet Healthcare had its price target raised by analysts at Royal Bank Of Canada from $253.00 to $277.00. They now have an “outperform” rating on the stock.
• 2/12/2026 – Tenet Healthcare had its price target raised by analysts at KeyCorp from $225.00 to $250.00. They now have an “overweight” rating on the stock.
• 2/12/2026 – Tenet Healthcare had its price target raised by analysts at Jefferies Financial Group Inc. from $250.00 to $265.00. They now have a “buy” rating on the stock.
• 2/3/2026 – Tenet Healthcare had its “buy” rating reaffirmed by analysts at UBS Group AG.
• 2/3/2026 – Tenet Healthcare had its price target raised by analysts at Royal Bank Of Canada from $252.00 to $253.00. They now have an “outperform” rating on the stock.
• 1/31/2026 – Tenet Healthcare was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
• 1/18/2026 – Tenet Healthcare was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
• 1/10/2026 – Tenet Healthcare was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating.
• 1/7/2026 – Tenet Healthcare had its “buy” rating reaffirmed by analysts at TD Cowen.
• 1/7/2026 – Tenet Healthcare had its price target lowered by analysts at Wells Fargo & Company from $252.00 to $229.00. They now have an “overweight” rating on the stock.
• 1/7/2026 – Tenet Healthcare had its price target lowered by analysts at TD Cowen from $233.00 to $230.00. They now have a “buy” rating on the stock.
• 12/29/2025 – Tenet Healthcare was upgraded by analysts at Weiss Ratings from a “hold (c+)” rating to a “buy (b-)” rating.
• 12/27/2025 – Tenet Healthcare was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
• 12/22/2025 – Tenet Healthcare had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/18/2025 – Tenet Healthcare had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $247.00 price target on the stock.
• 12/15/2025 – Tenet Healthcare was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the stock in a transaction that occurred on Monday, December 15th. The shares were sold at an average price of $197.47, for a total value of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.